Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_2
3
60%
Ph not_applicable
1
20%
Ph phase_1
1
20%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
3(60.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(1)
Terminated(1)

Detailed Status

Not yet recruiting3
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 23 (60.0%)
N/A1 (20.0%)

Trials by Status

completed120%
not_yet_recruiting360%
terminated120%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingphase_2

DaxibotulinumtoxinA for Blepharospasm

NCT07489430
not_yet_recruitingnot_applicable

Effectiveness of an Interprofessional Approach to the Treatment of Spasticity With Botulinum Toxin & Non-pharmacological Therapies

NCT07160699
not_yet_recruitingphase_1

Study of the Drug B11-FC (Botulism Treatment)

NCT06580236
terminatedphase_2

Safety and Efficacy of the Use of Botox on Acne

NCT00765375
completedphase_2

Botulinum Toxin in Burning Mouth Syndrome

NCT02964728

Clinical Trials (5)

Showing 5 of 5 trials
NCT07489430Phase 2

DaxibotulinumtoxinA for Blepharospasm

Not Yet Recruiting
NCT07160699Not Applicable

Effectiveness of an Interprofessional Approach to the Treatment of Spasticity With Botulinum Toxin & Non-pharmacological Therapies

Not Yet Recruiting
NCT06580236Phase 1

Study of the Drug B11-FC (Botulism Treatment)

Not Yet Recruiting
NCT00765375Phase 2

Safety and Efficacy of the Use of Botox on Acne

Terminated
NCT02964728Phase 2

Botulinum Toxin in Burning Mouth Syndrome

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5